This post gives comprehensive information about the tender offer to be made by Medtronic for EOFlow, including a discussion on the cancellation risks and the allocation volume that can be targeted.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.